WHICH FACTORS HAVE INFLUENCE ON THE MORBIDITY, INITIATION OF DIALYSIS AND MORTALITY OF PATIENTS WITH CKD STAGE 4 AND 5 NOT ON DIALYSIS? FINAL RESULTS FROM THE PECERA STUDY

被引：1

作者：

Luis Gorriz, Jose ^{[1
]}

Molina, Pablo ^{[1
]}

Javier Torralba, F. ^{[2
]}

Del Pozo, Carlos ^{[3
]}

Escudero, Veronica ^{[1
]}

Martin-Rivas, Josefa ^{[4
]}

Lopez-Menchero, Ramon ^{[5
]}

Castro, Cristina ^{[1
]}

Vizcaino, Belen ^{[1
]}

Pallardo, Luis M. ^{[1
]}

机构：

[1] Hosp Univ Dr Peset, Nephrol, Valencia, Spain

[2] Gen Hosp, Nephrol, Alicante, Spain

[3] Hosp Alcoi, Nephrol, Alcoy, Spain

[4] Hosp Elda, Nephrol, Elda, Spain

[5] Hosp Alcoi, Nephrol, Alcoy, Spain

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷

关键词：

D O I：

10.1093/ndt/gfv175.15

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

FP333

引用

页数：1

共 50 条

[21] Low Magnesium Predicts Cardiovascular Outcomes in Pre-Dialysis CKD Patients: Results from the KNOW-CKD Study
Kang, Minjung
Kang, Eunjeong
Han, Seung Seok
Ahn, Curie
Oh, Kook-Hwan
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 740 - 740
[22] Low Magnesium Is Associated with Weak Bone Strength in Pre-Dialysis CKD Patients: Results from the KNOW-CKD Study
Kang, Minjung
Kang, Eunjeong
Ahn, Curie
Oh, Kook-Hwan
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 216 - 216
[23] Severity of proteinuria and mortality in patients with chronic kidney disease stage 4-5 pre-dialysis
Cerezo, Isis
Hernandez-Gallego, Roman
Ruiz, Belen
Fernandez, Noemi
Martin, Maria Victoria
Barroso, Sergio
Caravaca, Francisco
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 192 - 192
[24] Perceived mental health at the start of dialysis as a predictor of morbidity and mortality in patients with end-stage renal disease (CALVIDIA Study)
Revuelta, KL
López, FJG
Moreno, FD
Alonso, J
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (09) : 2347 - 2353
[25] It is available as intravenous (for CKD stage 5) and oral capsule formulations (for CKD stages 3 and 4,[18] and for CKD stage 5 in patients undergoing haemodialysis or peritoneal dialysis[52]) (vol 67, pg 1987, 2007)
不详
DRUGS, 2007, 67 (17) : 2556 - 2556
[26] The association of mortality and hospitalization with hemoglobin (Hb) and missed dialysis treatments in stage 5 chronic kidney disease (CKD) patients with and without cardiac comorbidities
Ofsthun, NJ
LaBrecque, J
Keen, M
Youngson, HI
Krishnan, M
Lazarus, JM
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V268 - V269
[27] Mortality and Quality of Life in Elderly Patients on Dialysis in New Zealand: Results from the Dialysis Outcomes in the ≥65s Study (DOS65+)
Pearson, G. M.
Walker, R.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S85 - S86
[28] Hemoglobin and ESA Dose Values in CKD Patients not on Dialysis after Switching to CERA: Results from the Multicenter Observational Last Study
Franz, S.
Corsenca, A.
Meier, P.
Phan, O.
Komarek, A.
Meffert, G.
SWISS MEDICAL WEEKLY, 2011, 141 : 18S - 19S
[29] RIGHT VENTRICULAR FUNCTION IN CKD STAGE 5 PATIENTS WITH END-STAGE RENAL DISEASE STARTING DIALYSIS THERAPY. A TISSUE DOPPLER IMAGING STUDY
Zayed, Bahaa El-Din
Said, Kareem
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 232 - 232
[30] SNORING IS A STRONG AMPLIFIER OF THE RISK BY HEART FAILURE FOR ALL CAUSE AND CARDIOVASCULAR MORTALITY IN CHRONIC KIDNEY DISEASE PATIENTS ON DIALYSIS (STAGE 5D-CKD)
Torino, Claudia
D'Arrigo, Graziella
Postorino, Maurizio
Tripepi, Giovanni
Mallamaci, Francesca
Zoccali, Carmine
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 479 - 479

← 1 2 3 4 5 →